title: The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer.
authors.forename: U
authors.initials: U
authors.lastname: Mallick
authors.forename: C
authors.initials: C
authors.lastname: Harmer
authors.forename: A
authors.initials: A
authors.lastname: Hackshaw
mesh_terms: D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013964:Thyroid Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D013965:Thyroidectomy; D013972:Thyrotropin / Q000008:administration & dosage*
chemical_list: D006728:Hormones; D007457:Iodine Radioisotopes; D013972:Thyrotropin